Is M65 really better than M30 as a biomarker of hepatic fibrosis?
Yusuf Yilmaz, Ramazan Kurt – 12 December 2011
Yusuf Yilmaz, Ramazan Kurt – 12 December 2011
Bryan Cobb, Regis A. Vilchez – 12 December 2011
Jérôme Boursier, Paul Calès – 12 December 2011
Giada Sebastiani, Alfredo Alberti – 12 December 2011
Kama A. Wlodzimirow, Saeid Eslami, Ameen Abu‐Hanna, Martin Nieuwoudt, Robert A.F.M. Chamuleau – 12 December 2011
William Kemp, Stuart Roberts – 12 December 2011
Elina Teicher, Jean‐Charles Duclos‐Vallée – 7 December 2011
Lin Xie, Naotsugu Ichimaru, Miwa Morita, Jiajie Chen, Ping Zhu, Jihong Wang, Peter Urbanellis, Itay Shalev, Shizuko Nagao, Atsushi Sugioka, Liang Zhong, Norio Nonomura, Shiro Takahara, Gary A. Levy, Xiao‐Kang Li – 7 December 2011 – Here we examined whether the expression of a novel immunoregulatory gene set could be used to predict outcomes in murine models of rapamycin‐induced cardiac tolerance, spontaneous hepatic tolerance, and cardiac rejection.
James Y. Findlay – 7 December 2011
Ailton Sepulveda, Olivier Scatton, Hadrien Tranchart, Hervé Gouya, Fabiano Perdigao, Fabien Stenard, Denis Bernard, Filomena Conti, Yvon Calmus, Olivier Soubrane – 6 December 2011 – Split liver transplantation (SLT) using extended right grafts is associated with complications related to ischemia of hepatic segment 4 (S4), and these complications are associated with poor outcomes. We retrospectively analyzed 36 SLT recipients so that we could assess the association of radiological, biological, and clinical features with S4 ischemia.